Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

New Jersey Legislature

Sen. Oroho Bill to Remove Red Tape from Pharmaceutical Industry Passes Senate

Trenton Capital Dome  MoonTrenton, NJ, July 8, 2016 — Legislation sponsored by Senator Steve Oroho (R-Sussex, Warren, Morris) to make the registration process easier for pharmaceutical companies passed the New Jersey Senate.  The measure came out of the New Jersey Red Tape Review Commission.

“The seemingly never ending list of regulations and rules has handcuffed business in this state for far too long,” Senator Oroho said.  “Six years after it was created, the Red Tape Review Commission is still finding ways to cut back the bureaucracy and make it easier for entrepreneurs and job creators to grow their businesses in the state. This bill reduces the time it takes for drug companies to set up shop in New Jersey.” Continue reading

BioNJ Applauds Passage of SJR57/AJR46 to Create a New Jersey Biotechnology Task Force

BioNJ SquareTrenton, NJ, July 2, 2016BioNJ, the trade association for New Jersey’s life sciences industry, applauded the New Jersey Senate on its passage on Monday, June 27 of SJR57/AJR46, a joint resolution creating a New Jersey Biotechnology Task Force.

The Task Force is intended to communicate with the biotechnology industry and develop recommendations for actions that the Legislature and State can take to retain existing companies and attract new ones. BioNJ advocated for this initiative throughout the process.

“BioNJ thanks the New Jersey Senate for its timely action to pass SJR57, the companion bill to AJR46 which the Assembly passed last year,” said Debbie Hart, BioNJ President and CEO. Continue reading

NJ Senate President Stephen Sweeney Pushing for Paid Sick Leave Law, Taxing Hospitals

Trenton, NJ, September 1, 2015 ― Susan K. Livio reports in The Star-Ledger that State Senate President Stephen Sweeney says he remains committed to passing legislation that would require businesses to provide paid sick days and for nonprofit hospitals to pay property taxes.

But he doesn’t see either issue gaining momentum until after the Assembly elections in November. Continue reading

Insurer, New Jersey Medical Associations Seek Solution to Surprise Out-of-Network Medical Bills

Woodland Park, NJ, August 24, 2015 ― Lindy Washburn reports in The Record that New Jersey’s largest health insurance company and organizations representing doctors and hospitals have held private discussions over the summer about legislation to protect consumers from surprise medical bills.

They haven’t hammered out a compromise yet over the toughest issue — how to determine how much to pay a provider who isn’t part of an insurance network — but one participant expressed optimism. Continue reading

New Jersey Lawmakers Push for ‘Right to Try’ Unapproved Drugs for Terminally Ill Patients

Trenton, NJ, August 21, 2015 ― Kevin McArdle reports on New Jersey 101.5 that a group of New Jersey lawmakers is hoping to give terminally ill people in the Garden State access to medications that are in the clinical trial stage, but have not yet been approved by the Food and Drug Administration (FDA).

Currently, 24 states have enacted a “Right to Try” law, though no state in the Northeast has yet to pass such a law. Continue reading

Governor Christie Strengthens New Jersey’s Prescription Monitoring Program to Further Curb Prescription Drug Abuse

Trenton, NJ, July 20, 2015 ― Empowering healthcare professionals with effective tools to join the fight against prescription drug abuse, Governor Chris Christie signed legislation that expands the New Jersey Attorney General’s Division of Consumer Affairs Prescription Monitoring Program (PMP), an online database that tracks the prescription sale of drugs classified as controlled dangerous substances (CDS).

The bill, S1998, expands existing law with regard to access, registration, and utilization of the NJPMP. The new changes will help prevent “doctor shopping” that often occurs with prescription and opioid abuse.

“We have taken great strides in the fight against opiate abuse through a comprehensive strategy that encourages healthcare professionals, treatment providers, law enforcement, and members of the public to each embrace their role in addressing this healthcare crisis,” Governor Christie said. Continue reading

Governor Christie Signs Assemblywoman Angelini’s Prescription Drug Disposal Bill

Trenton, NJ, July 1, 2015 ― Legislation Deputy Republican Conference Leader Mary Pat Angelini sponsors that requires pharmacies and physicians to instruct patients on how to safely dispose unused prescribed controlled dangerous substances such as Percocet and Oxycontin has been signed into law by Gov. Chris Christie.

“The improper disposal of unused prescription drugs, especially medicines such as opiates, poses a danger to humans, animals and the environment,” said Assemblywoman Angelini, R-Monmouth. Continue reading

Bill to Permit Drug Court Completion with Medication-Assisted Treatment Heads to Governor Christie

Trenton, NJ, June 29, 2015 ― Legislation sponsored by Assembly Democrats Herb Conaway M.D., Raj Mukherji, Shavonda Sumter and Angelica Jimenez to permit successful completion of drug court programs notwithstanding use of medication-assisted treatment was approved 76-0 Thursday by the Assembly, giving it final legislative approval.

The bill now goes to Governor Chris Christie for consideration.

The bill (A3723) concerns the use of medication-assisted treatment by individuals involved in the state’s special probation drug court program as an alternative to incarceration. Continue reading

Bill to Make Biological Drug Alternatives More Widely Available Advances in New Jersey Senate

Trenton, NJ, June 9, 2015 ― A New Jersey Senate panel yesterday continued advancing legislation sponsored by Assembly Democrats Pamela Lampitt, Herb Conaway, Jr., M.D., Daniel Benson, Shavonda Sumter, Angel Fuentes and Nancy Pinkin to make it easier for consumers to obtain more cost-effective, “generic” versions of biological medicines used to treat conditions such as rheumatoid arthritis, anemia, psoriasis and various forms of cancer.

“The FDA has created a safe pathway to make alternative biological medicines more readily available on the market,” said Lampitt (D-Camden / Burlington).  “If there is a more cost-effective option to treat and cure various illnesses, then by all means we should be helping patients pursue it.” Continue reading

Bill Expanding Prescription Monitoring Program Sent to Governor Christie

Trenton, NJ, May 21, 2015 ― Legislation sponsored by Senate Majority Leader Loretta Weinberg and Senate Health Chairman Joseph F. Vitale to update, expand and improve the state’s Prescription Monitoring Program (PMP) to protect against patient abuse of addictive prescription medications was approved on May 18 by the Senate, sending the bill to Governor Chris Christie’s desk.

The Senate approved the bill by a vote of 34-0.  The Assembly approved it 74-0.  The law would take effect on the first day of the fourth month following the date of enactment. Continue reading